|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLES |
Department of Endocrinology and the Institute of Clinical and Experimental Neurosciences, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
(Correspondence should be addressed to I C van Nieuwpoort; Email: ic.vannieuwpoort{at}vumc.nl)
This paper was presented at the 5th Ferring International Paediatric Endocrinology Symposium, Baveno, Italy (2008). Ferring Pharmaceuticals has supported the publication of these proceedings.
The GH/IGF1 axis may play an important role in cognitive function. This theory is supported by the finding that both GH and IGF1 receptors are located in several brain areas such as the hippocampus, a brain area that is known to play an essential role in cognitive processes, especially memory and learning. However, the exact mechanism by which the GH/IGF1 axis influences the cognitive functions is still unknown. Furthermore, little is known about the cognition in adults with both childhood-onset and adult-onset GH deficiency (CO-GHD and AO-GHD). Recent data indicate that cognitive function, particularly attention and memory, in adults with GHD might be impaired. To date, only a limited number of studies have been conducted to study the effects of GH replacement therapy on cognitive function in adults with GHD. In this paper, the results of studies on cognitive functioning in GHD patients, in particular the results of the studies performed in adults with CO-GHD, and the effects of GH replacement therapy in these patients, will be discussed.
This article has been cited by other articles:
![]() |
E Nieves-Martinez, W E Sonntag, A Wilson, A Donahue, D P Molina, J Brunso-Bechtold, and M M Nicolle Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation J. Endocrinol., January 1, 2010; 204(1): 31 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bitoun, M. J. Finelli, P. L. Oliver, S. Lee, and K. E. Davies AF4 Is a Critical Regulator of the IGF-1 Signaling Pathway during Purkinje Cell Development J. Neurosci., December 9, 2009; 29(49): 15366 - 15374. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |